Research map: Compound muscle action potential amplitudes in newborn screen positive spinal muscular atrophy

Back to the article

Papers in this map

  1. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy · Richard S. Finkel · 2017 · 2364 citations · Cited by this paper
  2. 01 Gabapentinoids use disorder in the Neuropathic Pain Unit setting · 2026 · Related
  3. Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function · Kathryn J. Swoboda · 2005 · 480 citations · Cited by this paper
  4. Perturbational complexity index detects subclinical cortical changes in early multiple sclerosis · 2026 · Related
  5. Natural history of infantile‐onset spinal muscular atrophy · Stephen J. Kolb · 2017 · 421 citations · Cited by this paper
  6. The impact of neck extension on intraoperative neuromonitoring alerts in cervical myelopathy: A neurophysiological analysis · 2026 · Related
  7. The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability · Allan M. Glanzman · 2010 · 398 citations · Cited by this paper
  8. Internal and external validation of comprehensive high-frequency activity biomarkers for epilepsy surgery · 2026 · Related
  9. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial · Kevin A. Strauss · 2022 · 318 citations · Cited by this paper
  10. Causal involvement of two parietal regions in the integration of visuospatial attention and semantic memory · 2026 · Related
  11. 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7–9 November 2014, Heemskerk, The Netherlands · Richard S. Finkel · 2015 · 210 citations · Cited by this paper
  12. Age-related changes in sleep macroarchitecture across childhood and adolescence in a paediatric clinical polysomnography cohort · 2026 · Related
  13. Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases · Matthew E.R. Butchbach · 2016 · 200 citations · Cited by this paper
  14. Investigating short-term antiseizure medication effects on interictal epileptiform discharges in idiopathic generalized epilepsy · 2026 · Related
  15. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening · Yin‐Hsiu Chien · 2017 · 165 citations · Cited by this paper
  16. Exploring state changes/sleep-wake cycling in mechanically ventilated children using amplitude-integrated EEG · 2026 · Related
  17. Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) · Allan M. Glanzman · 2011 · 159 citations · Cited by this paper
  18. Perturbing the vestibular cortex with transcranial oscillatory currents uncovers early postural alterations in Parkinson’s disease · 2026 · Related
  19. Advances and limitations for the treatment of spinal muscular atrophy · John W. Day · 2022 · 140 citations · Cited by this paper
  20. F waves as a measure of enhanced spinal motoneuron excitability in primary lateral sclerosis · 2026 · Related
  21. Spectrum of Neuropathophysiology in Spinal Muscular Atrophy Type I · Brian N Harding · 2014 · 122 citations · Cited by this paper
  22. Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development · Matthew E.R. Butchbach · 2021 · 100 citations · Cited by this paper
  23. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening – Opportunity or Burden? · Wolfgang Müller‐Felber · 2020 · 73 citations · Cited by this paper
  24. Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres · Christoph Neuwirth · 2018 · 66 citations · Cited by this paper
  25. Changes in motor unit populations in motor neurone disease. · S A Carleton · 1979 · 65 citations · Cited by this paper
  26. CMAP changes upon symptom onset and during treatment in spinal muscular atrophy patients: lessons learned from newborn screening · Wen‐Chin Weng · 2020 · 45 citations · Cited by this paper
  27. Gene-Targeting Therapeutics for Neurological Disease: Lessons Learned from Spinal Muscular Atrophy · Bhavya Ravi · 2021 · 38 citations · Cited by this paper
  28. Insights into genotype–phenotype correlations in spinal muscular atrophy: A retrospective study of 103 patients · Florence Petit · 2010 · 37 citations · Cited by this paper
  29. Evaluation of risdiplam efficacy in 5q spinal muscular atrophy: A systematic comparison of electrophysiologic with clinical outcome measures · Tobias Keßler · 2023 · 29 citations · Cited by this paper
  30. Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA) · S. Lefebvre · 2020 · 23 citations · Cited by this paper
  31. Georgia state spinal muscular atrophy newborn screening experience: Screening assay performance and early clinical outcomes · Kathryn Elkins · 2022 · 23 citations · Cited by this paper
  32. A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy · Rémi Barrois · 2023 · 23 citations · Cited by this paper
  33. Pushing the boundaries: future directions in the management of spinal muscular atrophy · Fiona Moultrie · 2025 · 18 citations · Cited by this paper
  34. In utero therapy for spinal muscular atrophy: closer to clinical translation · Eduardo Fidel Tizzano · 2025 · 18 citations · Cited by this paper
  35. Complex SMN Hybrids Detected in a Cohort of 31 Patients With Spinal Muscular Atrophy · Mar Costa‐Roger · 2024 · 17 citations · Cited by this paper
  36. Compound Muscle Action Potential (CMAP) Amplitude Trajectories and Pattern in Adults with 5q‐Spinal Muscular Atrophy Receiving Nusinersen Therapy: A Multicenter, Binational Observational Study · Bogdan Bjelica · 2025 · 7 citations · Cited by this paper
  37. Changes in electrophysiological findings of spinal muscular atrophy type I after the administration of nusinersen and onasemnogene abeparvovec: two case reports · Tomoko Mizuno · 2023 · 2 citations · Cited by this paper
  38. Electrodiagnostic and Functional Biomarkers for Non‐Ambulatory Children With Late‐Onset Spinal Muscular Atrophy · Mariana Minei Ogata · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)